| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.09 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.08 | 0.1 |